Question explored with the scientific record
Started from a private conversation ↓
Is extremely low LDL linked to higher risks like hemorrhagic stroke or cancer?
The short version: yes, very low LDL is linked to a higher risk of hemorrhagic stroke, and the cancer link is less clear but worth watching in older adults.
A 2025 meta-analysis covering 50 million participants found that each 1 mmol/L drop in LDL was linked to about a 17% higher risk of intracerebral hemorrhage (the most common kind of hemorrhagic stroke) [17]. The same pattern held for total cholesterol: lower levels meant more bleeding strokes [17]. An older study from 2002 found that people with total cholesterol in the bottom quarter had more than 10 times the odds of having cerebral microbleeds on MRI, which are small warning leaks in the brain [16]. The Rotterdam Study also found that low triglycerides, not just low LDL, predicted more brain bleeds [15].
The cancer picture is more mixed. The big Heart Protection Study, a randomized trial of 20,536 people, found that lowering LDL with simvastatin did not increase cancer over 5 years [4]. But the PROSPER trial in older adults (mean age 75) found that those on pravastatin had 25% more new cancer diagnoses than the placebo group [6, 7]. A 2008 commentary pointed out that in PROSPER, the increase in cancer deaths actually matched the decrease in heart deaths, leaving overall death unchanged [7]. The same commentary noted that in the TNT trial, older adults on high-dose atorvastatin showed a trend toward more cancer deaths [7]. A 2021 meta-analysis of 84 studies found that LDL itself showed no clear link to colorectal cancer risk [8].
What matters here is that the evidence for harm from low LDL comes from people who got there through statins, not from people with naturally low numbers. The trials that pushed LDL below 40 used high-dose statins in sick patients. Whether a 73-year-old with a spontaneously low LDL faces the same risks is not settled by these studies.
My call: very low LDL is linked to a higher risk of hemorrhagic stroke, and the cancer signal in older adults on statins is real enough to take seriously. If your LDL of 36 came from medication, the risk-benefit calculation changes. If it is natural, the stroke risk still applies but the cancer concern is less clear.
Confidence: moderate for the hemorrhagic stroke link, low for the cancer link in someone with naturally low LDL.
Sources used 7
-
The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]
A large, randomized placebo-controlled trial (Heart Protection Study) in 20,536 high-risk UK adults shows that lowering LDL cholesterol with simvastatin 40 mg daily for about 5 years reduces vascular mortality by ~17% and major vascular events by ~25% without increasing non-vasc…
DOI: 10.1186/1741-7015-3-6 -
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
The PROSPER trial demonstrated that pravastatin treatment in elderly individuals at risk of vascular disease significantly reduced the incidence of coronary events but had no effect on stroke risk, while raising concerns about a higher incidence of new cancer diagnoses in the tr…
DOI: 10.1016/s0140-6736(02)11600-x -
Do Statins Prevent or Promote Cancer?
A commentary argues that statins may promote cancer in certain populations, particularly the elderly and those with prior cancer, possibly via statin-induced increases in regulatory T cells that impair antitumor immunity, and cites trial evidence of increased cancer incidence.
DOI: 10.3747/co.v15i2.235 -
Association between cardiovascular risk factors and colorectal cancer: A systematic review and meta-analysis of prospective cohort studies
A comprehensive meta-analysis of 84 prospective cohort studies (over 52 million participants) showing that several cardiovascular risk factors—especially obesity, higher BMI, smoking, diabetes, hypertension, and dyslipidemia components—are associated with increased colorectal ca…
DOI: 10.1016/j.eclinm.2021.100794 -
Serum Lipid Levels and the Risk of Intracerebral Hemorrhage: The Rotterdam Study
A large, population-based prospective study (Rotterdam Study) showing that low serum triglyceride levels are independently associated with an increased risk of intracerebral hemorrhage and with the presence of deep/infratentorial cerebral microbleeds, while HDL- and LDL-choleste…
DOI: 10.1161/ATVBAHA.111.234948 -
Low Concentration of Serum Total Cholesterol Is Associated With Multifocal Signal Loss Lesions on Gradient-Echo Magnetic Resonance Imaging
This study investigates whether lipid abnormalities, especially very low serum total cholesterol and high HDL cholesterol, along with hypertension and leukoaraiosis, are associated with multifocal signal loss lesions seen on gradient-echo MRI, a marker linked to cerebral microbl…
DOI: 10.1161/01.STR.0000036092.23649.2E -
Relationship between serum lipids and the risk of hemorrhagic stroke: a meta-analysis of 50 million participants from prospective cohort studies
A comprehensive meta-analysis using continuous-variable and dose–response approaches to quantify how serum lipids (total cholesterol, LDL-C, HDL-C, and triglycerides) relate to hemorrhagic stroke risk (overall HS and subtypes ICH/SAH) in community-based populations, revealing in…
DOI: 10.1186/s12944-025-02698-0